Ethopabate,
ETHOPABATE,
Methyl 4-acetamido-2-ethoxybenzoate,
59-06-3,
Ethopabat,
Benzoic acid, 4-(acetylamino)-2-ethoxy-, methyl ester,
Ethyl Pabate,
UNII-F4X3L6068O,
Methyl 4-(acetylamino)-2-ethoxybenzoate,
Amprol Plus (veterinary),
EINECS 200-414-3,
4-Acetamido-2-ethoxybenzoesaeuremethylester,
GOVWOKSKFSBNGD-UHFFFAOYSA-N,
F4X3L6068O,
Methyl 2-ethoxy-4-acetamidobenzoate,
MFCD00075809,
NCGC00160624-01,
DSSTox_CID_26264,
DSSTox_RID_81491,
DSSTox_GSID_46264,
Q-201078,
CAS-59-06-3,
Ethopabate [USP:BAN],
Ethopabate [USAN:BAN],
Ethopabate (USP),
Ethopabate (125mg),
AC1L1LNO,
KSC496M0F,
SCHEMBL540932,
CHEMBL458769,
ZINC1387,
DTXSID6046264,
CTK3J6602,
HY-B2138,
KS-00000YJ8,
Tox21 111943,
Tox21_111943,
ANW-44496,
Methyl 4-acetamido-2-ethoxy-benzoate,
AKOS015892662,
Tox21_111943_1,
CCG-213430,
CM12343,
CS-8028,
NCGC00160624-02,
NCGC00160624-03,
NCGC00160624-04,
AJ-08011,
AK-93466,
AS-11898,
CJ-00046,
SY226309,
AB0010964,
AX8008677,
DB-053312,
LS-175976,
RT-003113,
ST2407234,
FT-0625739,
4-Acetamido-2-ethoxybenzoic acid methyl ester,
MFCD00075809 (95%),
4-acetamido-2-ethoxy-benzoic acid methyl ester,
4-acetylamino-2-ethoxybenzoic acid methyl ester,
D08916,
Ethopabate, VETRANAL(TM), analytical standard,
M-1751,
4-Acetylamino-2-ethoxy-benzoic acid methyl ester,
AB01563313_01,
075E809,
4-Acetylamino-2-ethoxy-benzoic acid, methyl ester,
SR-01000944203,
I04-0433,
SR-01000944203-1,
Ethopabate, British Pharmacopoeia (BP) Reference Standard,
Ethopabate (4-Acetylamino-2-ethoxy-benzoic acid methyl ester),
Ethopabate, United States Pharmacopeia (USP) Reference Standard,
Mixture Name,
Ethopabate [BAN],
C12H15NO4,
CID6034,
Methyl4-acetamido-2-ethoxybenzoate,
methyl-4-acetamido-2-ethoxybenzoat,
C12-H15-N-O4,
4-(Acetylamino)-2-ethoxybenzoic acid methyl ester,